Laddar...
Erythropoietin either Prevents or Exacerbates Retinal Damage from Eye Trauma Depending on Treatment Timing
PURPOSE: Erythropoietin (EPO) is a promising neuroprotective agent and is currently in Phase III clinical trials for the treatment of traumatic brain injury. The goal of this study was to determine if EPO is also protective in traumatic eye injury. METHODS: The left eyes of anesthetized DBA/2J or Ba...
Sparad:
| I publikationen: | Optom Vis Sci |
|---|---|
| Huvudupphovsmän: | , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2017
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5206811/ https://ncbi.nlm.nih.gov/pubmed/27281679 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/OPX.0000000000000898 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|